Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Xencor Inc (NQ: XNCR ) 21.65 +0.38 (+1.79%) Streaming Delayed Price Updated: 4:00 PM EDT, Jul 26, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 426,148 Open 21.33 Bid (Size) 20.97 (10) Ask (Size) 22.35 (5) Prev. Close 21.27 Today's Range 21.33 - 22.39 52wk Range 16.49 - 26.84 Shares Outstanding 59,924,016 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Peeling Back The Layers: Exploring Xencor Through Analyst Insights June 14, 2024 Via Benzinga Xencor Regains CD20 x CD3 Bispecific T-Cell Engager June 13, 2024 From Xencor, Inc. Via Business Wire Performance YTD -3.82% -3.82% 1 Month +12.76% +12.76% 3 Month +2.75% +2.75% 6 Month +5.66% +5.66% 1 Year -9.75% -9.75% More News Read More Decoding 6 Analyst Evaluations For Xencor May 10, 2024 Via Benzinga XNCR Stock Earnings: Xencor Misses EPS, Misses Revenue for Q1 2024 May 09, 2024 Via InvestorPlace Xencor Reports First Quarter 2024 Financial Results May 09, 2024 From Xencor, Inc. Via Business Wire Analyst Scoreboard: 6 Ratings For Xencor April 16, 2024 Via Benzinga Unveiling 4 Analyst Insights On Xencor February 28, 2024 Via Benzinga Recap: Xencor Q4 Earnings February 27, 2024 Via Benzinga Xencor Appoints Bart Cornelissen as Chief Financial Officer April 09, 2024 From Xencor, Inc. Via Business Wire Xencor to Present at Upcoming Investor Conferences February 28, 2024 From Xencor, Inc. Via Business Wire Xencor Reports Fourth Quarter and Full Year 2023 Financial Results February 27, 2024 From Xencor, Inc. Via Business Wire Earnings Scheduled For February 27, 2024 February 27, 2024 Via Benzinga Earnings Preview: Xencor February 26, 2024 Via Benzinga Navigating 4 Analyst Ratings For Xencor January 22, 2024 Via Benzinga Preview: Xencor's Earnings November 06, 2023 Via Benzinga Xencor to Host Webcast to Review Fourth Quarter and Full Year 2023 Financial Results and Provide Vudalimab Clinical Update February 20, 2024 From Xencor, Inc. Via Business Wire Xencor to Present at the 42nd Annual J.P. Morgan Healthcare Conference January 03, 2024 From Xencor, Inc. Via Business Wire Dane Leone Joins Xencor as Senior Vice President, Corporate Strategy January 02, 2024 From Xencor, Inc. Via Business Wire Xencor Reports Third Quarter 2023 Financial Results November 07, 2023 From Xencor, Inc. Via Business Wire Xencor Sells Portion of Royalties and Milestones from Ultomiris® and Monjuvi® to OMERS Life Sciences for $215 Million November 07, 2023 From Xencor, Inc. Via Business Wire Xencor Presents Preclinical Data from Multiple XmAb® Research Programs at the SITC Annual Meeting November 03, 2023 From Xencor, Inc. Via Business Wire Xencor to Host Third Quarter 2023 Financial Results Webcast and Conference Call on November 7, 2023 October 31, 2023 From Xencor, Inc. Via Business Wire Xencor Announces Planned Retirement of Chief Financial Officer John Kuch October 26, 2023 From Xencor, Inc. Via Business Wire Earnings Scheduled For November 7, 2023 November 07, 2023 Via Benzinga Stocks That Hit 52-Week Lows On Tuesday October 03, 2023 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
